FSHD Brochure_

Literature
1. American Academy of Neurology. 2015. Summary of Evidence-based Guideline for patients and their families
facioscapulohumeral muscular dystrophy. Minneapolis, MN: American Academy of Neurology.
2. FSH‐DY Group. 1997. A prospective, quantitative study of the natural history of facioscapulohumeral muscular
dystrophy (FSHD): implication for therapeutic trials. Neurology, 48: 38–46.
3. IJspeert, J., Janssen, R.M.J., Murgia, A. Pisters, M.F. Cup, E.H.C. Groothuis, J.T. Van Alfen, N. 2013. Efficacy of a
combined physical and occupational therapy intervention in patients with subacute neuralgic amyotrophy:
A pilot study. NeuroRehabilitation, 33(4): 657‒665.
4. Informatie voor de huisarts over FSHD. 2015. Spierziekten Nederland, Vereniging Samenwerkende Ouder- en
Patiëntenorganisaties, Nederlands Huisartsen Genootschap. https://fshdexpertisecentrum.nl/passende-zorg/
zorgverleners/huisartsenbrochure-fshd/
5. Jensen, M.P., Hoffman A.J,, Stoelb B.L., Abresch R.T., Carter G.T. and McDonald, C.M. 2008. Chronic pain
in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Archives of Physical Medicine and
Rehabilitation, 89:320–328.
6. Kalkman, J.S., Schillings, M.L., Van der Werf, S.P., Padberg, G.W., Zwarts, M,J,, Van Engelen, B.G. and Bleijenberg,
G. 2005. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. Journal of
Neurology, Neurosurgery and Psychiatry, 76(10): 1406–1409.
7. Kalkman, J.S., Schillings, M.L., Zwarts, M,J,, Van Engelen, B.G. and Bleijenberg, G. 2007. The development of
a model of fatigue in neuromuscular disorders: A longitudinal study. Journal of Psychosomatic Research,
62(5): 571–579.
8. King, W.M. and Pandya, S. 2009. Physical therapy & FSHD: Facioscapulohumeral muscular dystrophy:
A guide for patients & physical therapists. Watertown, MA: FSH Society.
9. Koninklijk Nederlands Genootschap voor Fysiotherapie. 2014. KNGF-standaard beweeginterventie chronische
pijn 2014. Amersfoort: KNGF.
10. Koninklijk Nederlands Genootschap voor Fysiotherapie. 2016. KNGF-richtlijn fysiotherapeutische dossiervoering
2016. Amersfoort: KNGF.
11. Lanser, A. 2015. FSHD in beeld: Onmacht en veerkracht. Wassenaar: FSHD Stichting.
12. Rijken, N.H., Van Engelen, B.G., Weerdesteyn, V. and Geurts, A.C. 2015. Clinical functional capacity testing in
patients with facioscapulohumeral muscular dystrophy: Construct validity and interrater reliability of antigravity
tests. Archives of Physical Medicine and Rehabilitation, 96: 2201–2206.
13. Rijken, N.H.M., Van Engelen, B.G.M., De Rooy, J.W.J., Geurts, A.C.H. and Weerdesteyn, V. 2014. Trunk muscle
involvement is most critical for the loss of balance control in patients with facioscapulohumeral muscular
dystrophy. Clinical Biomechanics, 29(8): 855–860.
14. Stubgen, J-P. 2008. Facioscapulohumeral muscular dystrophy: A radiologic and manometric study of the
pharynx and esophagus. Dysphagia, 23(4): 341–347.
15. Tawil, R., Kissel, J.T., Heatwole, C., Pandya, S., Gronseth, G. And Benatar, M. 2015. Evidence-based guideline
summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of
the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of
Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular &
Electrodiagnostic Medicine. Neurology, 85(4): 357–364.
16. Tawil, R. and Van der Maarel, S.M. 2006. Facioscapulohumeral muscular dystrophy. Muscle & Nerve, 34: 1–15.
17. Tawil, R., Van der Maarel, S., Padberg, G.W. and Van Engelen, B.G.M. 2010. 171st ENMC International Workshop:
Standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscular Disorders,
20(7): 471–475.
18. Van der Kooi, E.L., Kalkman, J.S., Lindeman, E., Hendriks, J.C.M., Van Engelen, B.G.M., Bleijenberg, G. and
Padberg, G.W. 2007. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular
dystrophy. Journal of Neurology, 254: 931–940.
19. Van der Maarel, S.M. and Frants, R.R. 2005. The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral
muscular dystrophy. American Journal of Human Genetics, 76(3): 375–386.
20. Voet, N., Bleijenberg, G., De Groot, I., Padberg, G., Van Engelen, B. and Geurts, A. 2014. Both aerobic exercise
training and cognitive behavior therapy reduce chronic fatigue in patients with facioscapulohumeral muscular
dystrophy: A randomized controlled trial. Annals of Physical and Rehabilitation Medicine, 57, supplement
1: e96.
21. Voet N.B.M., Van der Kooi E.L., Van Engelen, B.G.M. and Geurts, A.C.H. 2013. Strength training and aerobic
exercise training for muscle disease. Cochrane Database of Systematic Reviews, 12: CD003907.
22. Wilbers, J., Frants, R.R., Van Engelen, B.G.M., Padberg, G.W. and Van der Maarel, S.M. 2010. [Facioscapulohumeral
muscular dystrophy]. Nederlands Tijdschrift voor Tandheelkunde, 117(1): 11–14.
23. Wohlgemuth, M., De Swart, B.J.M., Kalf, J.G., Joosten, F.B.M., Van der Vliet, A.M. and Padberg, G.W. 2006.
Dysphagia in facioscapulohumeral muscular dystrophy. Neurology, 66(12): 1926–1928.
24. World Health Organization. 2001. International Classification of Functioning, Disability and Health (ICF).
14
http://www.who.int/classifications/icf/en/.